Arduini Peter J's Form 4 filing
Integra Lifesciences Holdings Corp (IART) · filed Sep 7, 2021
- Accession no.
- 0001209191-21-054970
- Filed
- Sep 7, 2021
- Trade date
- Sep 2-3, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $8.99M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arduini Peter JCIK 0001323134 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Common Stock | MOption exerciseAcquired | +71,829 | $20.88 | +$1,499,789.52 | 288,542 | Direct | |
| Sep 2, 2021 | Common Stock | SSaleDisposed | −71,829 | $75.97 | −$5,456,849.13 | 216,713 | Direct | |
| Sep 3, 2021 | Common Stock | MOption exerciseAcquired | +46,605 | $20.88 | +$973,112.4 | 263,318 | Direct | |
| Sep 3, 2021 | Common Stock | SSaleDisposed | −46,605 | $75.75 | −$3,530,328.75 | 216,713 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Common Stock | MOption exerciseDisposed | −71,829 | $0.00 | $0 | 46,605 | Direct | |
| Sep 3, 2021 | Common Stock | MOption exerciseDisposed | −46,605 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.